金河生物(002688.SZ):金黴素預混劑產品批准文號完成變更登記並獲得獸藥產品批准文號
格隆匯3月6日丨金河生物(002688.SZ)公佈,公司近日已完成金黴素預混劑產品批准文號由“獸藥添字”變為“獸藥字”變更登記工作,並獲得獸藥產品批准文號批件。
公司產品金黴素預混劑的產品批准文號變更登記是根據《獸藥管理條例》、《飼料和飼料添加劑管理條例》和《中華人民共和國農業農村部公告第194號》等法律法規的相關要求進行的變更。金黴素預混劑產品批准文號由“獸藥添字”變更為“獸藥字”後,產品用途主要是針對斷奶仔豬腹瀉、育肥豬常見呼吸道與腸道感染以及母豬的產前產後的各種混合感染,做為治療和治療性預防的用途使用。公司將按照獸藥管理的相關規定,組織金黴素產品的生產和銷售工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.